BACKGROUND AND OBJECTIVES: Given the paucity of high-quality safety/efficacy data on acute stroke therapies in patients with premorbid disability, they risk being routinely excluded from such therapies. We examined utilization of endovascular thrombectomy (EVT), associated workflow, and poststroke outcomes among patients with vs without premorbid disability. METHODS: We used national registry data on thrombolysis/EVT for the Czech Republic from 1 January 2016 to 31 December 2020. Premorbid disability was defined as prestroke modified Rankin Scale score (mRS) ≥3. We compared proportions of patients with vs without premorbid disability who received EVT and examined workflow times. We compared ΔmRS-change in mRS from prestroke to 3 months-in patients with vs without premorbid disability, in addition to intracerebral hemorrhage (ICH), mortality, and discharge NIHSS (National Institutes of Health Stroke Scale score), adjusting for age, sex, baseline NIHSS, and comorbidities, and verified using propensity score weighting (PSW) and matching for differences in treatment assignment. We stratified by age group (<65, 65-74, 75-84, ≥85 years) to explore outcome heterogeneity with vs without premorbid disability. RESULTS: Among 22,405 patients with ischemic stroke who received thrombolysis/EVT/both, 1,712 (7.6%) had prestroke mRS ≥ 3. Patients with prestroke disability were less likely to receive EVT vs those without (10.1% vs 20.7%, aOR: 0.30, 95% CI 0.24-0.36). When treated, they had longer door-to-arterial puncture times (median: 75 minutes, IQR: 58-100 vs 54, IQR: 27-77, adjusted difference: 12.5, 95% CI 2.68-22.3). Patients with prestroke disability receiving thrombolysis/EVT/both had worse ΔmRS (adjusted rate ratio, aIRR on PSW: 1.57, 95% CI 1.43-1.72), rates of 3-month mRS 5-6, discharge NIHSS, and mortality (aOR-PSW [mortality]: 2.54, 95% CI 1.92-3.34), while ICH did not significantly differ. 32.1% of patients with prestroke disability receiving thrombolysis/EVT/both successfully returned to prestroke state, but this proportion ranged from 19.6% for those older than 85 years to 66.0% for those younger than 65 years. Regardless of premorbid disability, EVT was associated with better outcomes including lower ΔmRS (aIRR-PSW: 0.87, 95% CI 0.83-0.91) and mortality, with no interaction of treatment effect by premorbid disability status (e.g., mortality pinteraction = 0.73). EVT recipients with premorbid disability did not differ significantly for several outcomes including ΔmRS (aIRR: 0.99, 95% CI 0.84-1.17) but were more likely to have 3-month mRS 5-6 (70.1% vs 39.5% without premorbid disability, aOR: 1.85, 95% CI 1.12-3.04). DISCUSSION: Patients with premorbid disability were less likely to receive EVT, had slower treatment times, and had worse outcomes compared with patients without premorbid disability. However, regardless of premorbid disability, patients fared better with EVT vs medical management and one-third with prestroke disability returned to their prestroke status.

Calgary Stroke Program Tomas Bata Regional Hospital Zlin Czech Republic

See more in PubMed

Ganesh A, Luengo-Fernandez R, Pendlebury ST, Rothwell PM. Long-term consequences of worsened poststroke status in patients with premorbid disability. Stroke. 2018;49(10):2430-2436. doi:10.1161/STROKEAHA.118.022416 PubMed DOI PMC

Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365(9453):82-93. doi:10.1016/S0140-6736(04)17670-8 PubMed DOI

Emberson J, Lees KR, Lyden P, et al. . Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935. doi:10.1016/S0140-6736(14)60584-5 PubMed DOI PMC

Young MJ, Regenhardt RW, Leslie-Mazwi TM, Stein MA. Disabling stroke in persons already with a disability: ethical dimensions and directives. Neurology. 2020;94(7):306-310. doi:10.1212/WNL.0000000000008964 PubMed DOI PMC

Fiehler J, Cognard C, Gallitelli M, et al. . European recommendations on organisation of interventional care in acute stroke (EROICAS). Eur Stroke J. 2016;1(3):155-170. doi:10.1177/2396987316659033 PubMed DOI PMC

Turc G, Bhogal P, Fischer U, et al. . European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg. 2019;11(6):535-538. doi:10.1136/neurintsurg-2018-014568 PubMed DOI

Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. . Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581-641. doi:10.1161/STR.0000000000000086 PubMed DOI

Powers WJ, Rabinstein AA, Ackerson T, et al. . 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. doi:10.1161/STR.0000000000000158 PubMed DOI

Cappellari M, Bosco M, Forlivesi S, et al. . Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the stroke unit. J Thromb Thrombolysis. 2016;42(4):593-599. doi:10.1007/s11239-016-1406-8 PubMed DOI

Gumbinger C, Ringleb P, Ippen F, et al. . Outcomes of patients with stroke treated with thrombolysis according to prestroke rankin scale scores. Neurology. 2019;93(20):e1834-e1843. doi:10.1212/WNL.0000000000008468 PubMed DOI

Bala F, Beland B, Mistry E, Almekhlafi MA, Goyal M, Ganesh A. Endovascular treatment of acute ischemic stroke in patients with pre-morbid disability: a meta-analysis. J Neurointerv Surg. 2023;15(4):343-349. doi:10.1136/neurintsurg-2021-018573 PubMed DOI

Goldhoorn RJB, Verhagen M, Dippel DWJ, et al. . Safety and outcome of endovascular treatment in prestroke-dependent patients. Stroke. 2018;49(10):2406-2414. doi:10.1161/STROKEAHA.118.022352 PubMed DOI

SITS. Safe Implementation of Thrombolysis in Stroke—International Stroke Register. sitsinternational.org

Polivka J, Polivka J Jr., Rohan V. Predictive and individualized management of stroke-success story in Czech Republic. EPMA J. 2018;9(4):393-401. doi:10.1007/s13167-018-0150-x PubMed DOI PMC

Registry of Stroke Care Quality. Accessed October 23, 2023. qualityregistry.eu

Mikulik R, Bar M, Belaskova S, et al. . Ultrashort door-to-needle time for intravenous thrombolysis is safer and improves outcome in the Czech Republic: Nationwide Study 2004 to 2019. J Am Heart Assoc. 2022;11(10):e023524. doi:10.1161/JAHA.121.023524 PubMed DOI PMC

Mikulik R, Bar M, Cernik D, et al. . Stroke 20 20: implementation goals for intravenous thrombolysis. Eur Stroke J. 2021;6(2):151-159. doi:10.1177/23969873211007684 PubMed DOI PMC

Fearon P, McArthur KS, Garrity K, et al. . Prestroke modified rankin stroke scale has moderate interobserver reliability and validity in an acute stroke setting. Stroke. 2012;43(12):3184-3188. doi:10.1161/STROKEAHA.112.670422 PubMed DOI

Quinn TJ, Taylor-Rowan M, Coyte A, et al. . Pre-stroke modified rankin scale: evaluation of validity, prognostic accuracy, and association with treatment. Front Neurol. 2017;8:275. doi:10.3389/fneur.2017.00275 PubMed DOI PMC

von Kummer R, Broderick JP, Campbell BC, et al. . The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46(10):2981-2986. doi:10.1161/STROKEAHA.115.010049 PubMed DOI

Beland B, Bala F, Ganesh A. Thrombolysis for acute ischemic stroke in patients with premorbid disability: a meta-analysis. Stroke. 2022:53(10):3055-3063. doi:10.1161/STROKEAHA.121.038374 PubMed DOI

Ramos LA, Kappelhof M, Van Os HJA, et al. . Predicting poor outcome before endovascular treatment in patients with acute ischemic stroke. Front Neurol. 2020;11:580957. doi:10.3389/fneur.2020.580957 PubMed DOI PMC

Austin PC, Yu AYX, Vyas MV, Kapral MK. Applying propensity score methods in clinical research in neurology. Neurology. 2021;97(18):856-863. doi:10.1212/WNL.0000000000012777 PubMed DOI PMC

matchit: Matching for Causal Inference [online]. Accessed February 5, 2024. rdocumentation.org/packages/MatchIt/versions/4.5.5/topics/matchit.

McDonough RV, Ospel JM, Majoie C, et al. . Clinical outcome of patients with mild pre-stroke morbidity following endovascular treatment: a HERMES substudy. J Neurointerv Surg. 2023;15(3):214-220. doi:10.1136/neurintsurg-2021-018428 PubMed DOI

Dreassi E. Poisson models. In: Michalos AC, ed. Encyclopedia of Quality of Life and Well-Being Research. Springer; 2014:4848-4850.

Benali F, Kappelhof M, Ospel J, et al. . Benefit of successful reperfusion achieved by endovascular thrombectomy for patients with ischemic stroke and moderate pre-stroke disability (mRS 3): results from the MR CLEAN Registry. J Neurointerv Surg. 2023;15(5):433-438. doi:10.1136/neurintsurg-2022-018853 PubMed DOI

Morris TP, White IR, Royston P. Tuning multiple imputation by predictive mean matching and local residual draws. BMC Med Res Methodol. 2014;14:75. doi:10.1186/1471-2288-14-75 PubMed DOI PMC

von Hippel PT. How many imputations do you need? A two-stage calculation using a quadratic rule. Sociological Methods Res. 2020;49(3):699-718. doi:10.1177/0049124117747303 DOI

Ganesh A, Fraser JF, Gordon Perue GL, et al. . Endovascular treatment and thrombolysis for acute ischemic stroke in patients with premorbid disability or dementia: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2022;53(5):e204-e217. doi:10.1161/STR.0000000000000406 PubMed DOI

Gensicke H, Strbian D, Zinkstok SM, et al. . Intravenous thrombolysis in patients dependent on the daily help of others before stroke. Stroke. 2016;47(2):450-456. doi:10.1161/STROKEAHA.115.011674 PubMed DOI

Saposnik G, Cote R, Rochon PA, et al. . Care and outcomes in patients with ischemic stroke with and without preexisting dementia. Neurology. 2011;77(18):1664-1673. doi:10.1212/WNL.0b013e31823648f1 PubMed DOI

Slawski DE, Salahuddin H, Shawver J, et al. . Mechanical thrombectomy in elderly stroke patients with mild-to-moderate baseline disability. Interv Neurol. 2018;7(5):246-255. doi:10.1159/000487333 PubMed DOI PMC

Callisaya ML, Purvis T, Lawler K, Brodtmann A, Cadilhac DA, Kilkenny MF. Dementia is associated with poorer quality of care and outcomes after stroke: an observational Study. J Gerontol A Biol Sci Med Sci. 2021;76(5):851-858. doi:10.1093/gerona/glaa139 PubMed DOI

Zupanic E, von Euler M, Kareholt I, et al. . Thrombolysis in acute ischemic stroke in patients with dementia: a Swedish registry study. Neurology. 2017;89(18):1860-1868. doi:10.1212/WNL.0000000000004598 PubMed DOI PMC

Renoux C, Coulombe J, Li L, Ganesh A, Silver L, Rothwell PM, Oxford Vascular Study. Confounding by pre-morbid functional status in studies of apparent sex differences in severity and outcome of stroke. Stroke. 2017;48(10):2731-2738. doi:10.1161/STROKEAHA.117.018187 PubMed DOI PMC

Saver JL, Goyal M, van der Lugt A, et al. . Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279-1288. doi:10.1001/jama.2016.13647 PubMed DOI

Saposnik G, Kapral MK, Cote R, et al. . Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis. J Neurol. 2012;259(11):2366-2375. doi:10.1007/s00415-012-6508-4 PubMed DOI

Zupanic E, Kåreholt I, Norrving B, et al. . Acute stroke care in dementia: a cohort study from the Swedish dementia and stroke registries. J Alzheimers Dis. 2018;66(1):185-194. doi:10.3233/JAD-180653 PubMed DOI PMC

de Havenon A, Castonguay A, Nogueira R, et al. . Prestroke disability and outcome after thrombectomy for emergent anterior circulation large vessel occlusion stroke. Neurology. 2021;97(19):e1914-e1919. doi:10.1212/WNL.0000000000012827 PubMed DOI PMC

Tanaka K, Yamagami H, Yoshimoto T, et al. . Endovascular therapy for acute ischemic stroke in patients with prestroke disability. J Am Heart Assoc. 2021;10(15):e020783. doi:10.1161/JAHA.121.020783 PubMed DOI PMC

Busl KM, Nogueira RG, Yoo AJ, Hirsch JA, Schwamm LH, Rost NS. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis. 2013;22(6):718-724. doi:10.1016/j.jstrokecerebrovasdis.2011.11.005 PubMed DOI PMC

Karlinski M, Kobayashi A, Czlonkowska A, et al. . Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke. Stroke. 2014;45(3):770-775. doi:10.1161/STROKEAHA.113.003744 PubMed DOI

Subic A, Cermakova P, Norrving B, et al. . Management of acute ischaemic stroke in patients with dementia. J Intern Med. 2017;281(4):348-364. doi:10.1111/joim.12588 PubMed DOI

Garcia-Ptacek S, Contreras Escamez B, Zupanic E, et al. . Prestroke mobility and dementia as predictors of stroke outcomes in patients over 65 years of age: a cohort study from the Swedish Dementia and Stroke Registries. J Am Med Dir Assoc. 2018;19(2):154-161. doi:10.1016/j.jamda.2017.08.014 PubMed DOI

Han TS, Fry CH, Gulli G, et al. . Prestroke disability predicts adverse poststroke outcome: a registry-based prospective cohort study of acute stroke. Stroke. 2020;51(2):594-600. doi:10.1161/STROKEAHA.119.027740 PubMed DOI

Ganesh A, Fladt J, Singh N, Goyal M. Efficacy and safety of mechanical thrombectomy in acute stroke patients with pre-morbid disability. Expert Rev Med Devices. 2022;19(8):641-648. doi:10.1080/17434440.2022.2124109 PubMed DOI